Janux
Janux is a California-based biotechnology company that develops and commercializes T cell-based immunotherapies for the treatment of cancer.
Business Model:
Revenue: $4.8M
Employees: 11-50
Industries / Tags:
Detailed Janux Information
Geographic Data
Address: 11099 N. Torrey Pines Road
City: La Jolla
State: CA
Zip: 92037
Country: US
Financial Info
Stage:
series b
Raised Last:
$125M
Raised Total:$192M
Social
Metrics
3,358,804Website Global Rank
4,415Website Monthly Traffic
Twitter Followers
Description
Janux is a California-based biotechnology company that develops and commercializes T cell-based immunotherapies for the treatment of cancer.
Contact Phone:
+18587504700
Contact Email:
Janux went public on 6/11/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/11/2021
IPO Valuation:
$678M
Ticker Symbol:
JANX
IPO Price:
$17/share
Amount Raised:
$223M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
